Trial Site Detail
Drug: |
Sorafenib (Nexavar, BAY 43-9006) |
|||
|---|---|---|---|---|
Trial: |
Sorafenib in Treating Patients With Malignant Gastrointestinal Stromal Tumor That Progressed During or After Previous Treatment With Imatinib Mesylate and Sunitinib Malate |
|||
| Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Ongoing, but not recruiting |
|||
Memorial Sloan Kettering1275 York Ave |
Principal Investigator: |
David D'Adamo, MD, PhD |
|---|---|
Contact: |
David D'Adamo, MD, PhD, 212-639-7573 |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Memorial Sloan Kettering Website: |
http://www.mskcc.org/mskcc/html/2270.cfm?Tab=All |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.